Mr. Riyaz Merali, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Suite B, Winooski, VT 05404 Phone: 802-655-3544 |
Dr. Michael S Skaar Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 |
John Joy, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-5473 |
Lara Elizabeth Dusek Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 E Spring St Apt A, Winooski, VT 05404 Phone: 703-731-6104 |
Chelsea Dawn Leblanc, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 |
Allison Pratt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 |
Lyndsi Branon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 |
Dr. Rebecca A Crittenden, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St Ste B, Winooski, VT 05404 Phone: 802-655-3544 Fax: 802-655-0123 |
News Archive
Resverlogix Corp. is pleased to announce today that it has filed additional new patent protection based on novel findings derived from its recently completed ASSERT Phase 2 clinical trial.
The hippocampus, a brain structure known to play a role in memory and spatial navigation, is essential to one's ability to recognize previously encountered events, objects, or people - a phenomenon known as recognition memory - according to new research from the departments of Neurosurgery and Psychology in the Perelman School of Medicine at the University of Pennsylvania.
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
› Verified 6 days ago